Skip to content

NEO

NeoGenomics, Inc.

Stock

$18.47+0.69 (+3.88%)Close Oct 2, 2026

Key figures

MetricLast 12 months5-year CAGR
Revenue$766M+10.4%
Gross profit$337M+11.1%
Operating income−$68M—
Net income−$52M—
EPS−$0.40—
Free cash flow−$7.4M—